Cargando…
Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
BACKGROUND: Adjuvant chemotherapy for stage III colon cancer is internationally accepted as standard treatment with established efficacy, but the usefulness of adjuvant chemotherapy for stage II colon cancer remains controversial. The major Western guidelines recommend adjuvant chemotherapy for “hig...
Autores principales: | Ishiguro, Megumi, Mochizuki, Hidetaka, Tomita, Naohiro, Shimada, Yasuhiro, Takahashi, Keiichi, Kotake, Kenjiro, Watanabe, Masahiko, Kanemitsu, Yukihide, Ueno, Hideki, Ishikawa, Toshiaki, Uetake, Hiroyuki, Matsui, Shigeyuki, Teramukai, Satoshi, Sugihara, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459783/ https://www.ncbi.nlm.nih.gov/pubmed/22769569 http://dx.doi.org/10.1186/1471-2407-12-281 |
Ejemplares similares
-
Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial
por: Ueno, Hideki, et al.
Publicado: (2019) -
Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial)
por: Ueno, Hideki, et al.
Publicado: (2020) -
Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial)
por: Ueno, Hideki, et al.
Publicado: (2021) -
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial
por: Mochizuki, I, et al.
Publicado: (2012) -
Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer
por: Ishiguro, Megumi, et al.
Publicado: (2013)